Recode Ventures — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
LabGeniuslabgeni.usin𝕏Oct 2017
LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.
AI & Machine LearningBiotechDeep TechLondon
Harrison Rickerby(Executive Officer, Director)
BoardJames Field(Executive Officer, Director)in
PartnerArmen A. Vidian· solo GP
Co-investorsAcequia Capital (AceCap)Air Street CapitalBackedBeast VenturesChampion Hill VenturesGigafund+9 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.